Geode Capital Management, LLC Chemo Centryx, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$22.17 - $51.8 $3.1 Million - $7.25 Million	139,999 Added 13.9%	1,146,933 $59.3 Million
Q2 2022 Aug 12, 2022	BUY	$15.36 - $27.51 $100,131 - $179,337	6,519 Added 0.65%	1,006,934 $25 Million
Q1 2022 May 13, 2022	BUY	$22.22 - $39.12 $1.52 Million - $2.67 Million	68,246 Added 7.32%	1,000,415 $25.1 Million
Q4 2021 Feb 11, 2022	SELL	$18.38 - $40.5 $59,735 - $131,625	-3,250 Reduced 0.35%	932,169 $33.9 Million
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $483,455 - $727,384	36,681 Added 4.08%	935,419 $16 Million
Q2 2021 Aug 13, 2021	BUY	$9.59 - $50.88 $429,900 - $2.28 Million	44,828 Added 5.25%	898,738 $12 Million
Q1 2021 May 12, 2021	BUY	$49.53 - $68.4 $2.92 Million - $4.04 Million	58,992 Added 7.42%	853,910 $43.8 Million
Q4 2020 Feb 12, 2021	BUY	$47.25 - $65.16 $2.21 Million - $3.05 Million	46,809 Added 6.26%	794,918 $49.2 Million
Q3 2020 Nov 13, 2020	BUY	$46.35 - $61.69 $1.82 Million - $2.42 Million	39,278 Added 5.54%	748,109 $41 Million
Q2 2020 Aug 13, 2020	BUY	$38.58 - $65.07 $2.87 Million - $4.83 Million	74,299 Added 11.71%	708,831 $40.8 Million
Q1 2020 May 14, 2020	BUY	$32.73 - $50.78 $2 Million - $3.1 Million	60,979 Added 10.63%	634,532 $25.5 Million
Q4 2019 Feb 13, 2020	BUY	$6.81 - $39.55 $388,714 - $2.26 Million	57,080 Added 11.05%	573,553 $22.7 Million
Q3 2019 Nov 12, 2019	SELL	$6.47 - $8.96 $145,827 - $201,949	-22,539 Reduced 4.18%	516,473 $3.5 Million
Q2 2019 Aug 14, 2019	BUY	$8.31 - $14.85 $1.48 Million - $2.64 Million	178,081 Added 49.34%	539,012 $5.01 Million
Q1 2019 May 14, 2019	BUY	$10.01 - $13.89 $270,410 - $375,224	27,014 Added 8.09%	360,931 $5.01 Million
Q4 2018 Feb 13, 2019	BUY	$9.15 - $12.26 $758,699 - $1.02 Million	82,918 Added 33.04%	333,917 $3.64 Million
Q3 2018 Nov 13, 2018	BUY	$10.49 - $13.72 $191,662 - $250,678	18,271 Added 7.85%	250,999 $3.17 Million
Q2 2018 Aug 14, 2018	SELL	$10.62 - $13.98 $284,934 - $375,083	-26,830 Reduced 10.34%	232,728 $3.06 Million
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $127,475 - $323,873	21,606 Added 9.08%	259,558 $3.53 Million
Q4 2017 Feb 13, 2018	SELL	$5.53 - $8.42 $21,871 - $33,301	-3,955 Reduced 1.63%	237,952 $1.42 Million
Q3 2017 Nov 14, 2017	BUY	$6.5 - $10.69 $269,340 - $442,961	41,437 Added 20.67%	241,907 $1.79 Million
Q2 2017 Aug 14, 2017	BUY	N/A	200,470	200,470 $1.88 Million

Others Institutions Holding CCXI

# of Institutions

Shares Held

66.3K

Call Options Held

Put Options Held

View Full List

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account